Lysine Tneophyllinate

赖氨酸茶碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLysine Tneophyllinate
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsAsthmaBronchitis, Chronic
Global Approved IndicationsAsthmaBronchitis, Chronic
Approved Indications in ChinaAsthmaBronchitis, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAsthmaBronchitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A